[听力文本资源] The United States has announced a new drug approval process for AIDS medicines for developing countries. The Health and Human Services Secretary announced it at a World Health Organization meeting in Geneva. The program will speed up the release of low-cost AIDS drugs to nations in Africa. Several different drugs are generally used together to control HIV, the virus that causes AIDS. The new policy urges drug companies to produce treatments that would combine up to three anti-HIV drugs in a single pill. Several drug companies say they have already started to develop combination products. Such efforts might require competing companies to work together. The new policy involves AIDS drugs purchased by the United States for developing countries. American officials say the new policy will help them make sure of the quality of the drugs. Some people have long accused the United States of protecting drug makers from competition from lower-cost versions of their drugs. They point out that there is already a list of AIDS drugs approved by the World Health Organization. This list includes genetic copies. But the WHO Director General says he welcomes the new approval program. He says AIDS drugs paid for by international agencies and governments must meet quality and safety requirements.[听力文本资源]1. [听力文本资源] What is the potential effect of the new drug approval process? [听力文本资源]A) It will force drug companies to invest more in research.B) It will increase the financial burden of the United States.C) It will provide African countries with cheaper AIDS drugs. D) It will promote the research and development of AIDS drugs.2. [听力文本资源] What does the new policy require drug companies to do? [听力文本资源]A) To ensure the quality of their drugs.B) To offer free drugs to people in poverty.C) To work together with competing companies.D) To combine several anti-HIV drugs in one pill. 3. [听力文本资源] What is the WHO Director General's attitude towards the new approval program? [听力文本资源]A) Supporting. B) Indifferent.C) Doubtful.D) Grateful.